Targeting the PI3K/Akt pathway for the treatment of ulcerative colitis: integrative regulatory features of traditional Chinese medicine
Frontiers in Pharmacology · 09.10.2025 · 16
DOI: 10.3389/fphar.2025.1620138 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 09.10.2025. Verfasst von Siying Niu und 1 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The development of ulcerative colitis (UC), a highly prevalent inflammatory bowel disease worldwide, is closely related to the key regulatory role of the PI3K/Akt signaling pathway. Although the use of Western drugs is the standard clinical treatment, the problems of drug resistance, side effects, and efficacy limitations are prominent. In contrast, Traditional Chinese Medicine (TCM), with the advantages of multi-target regulation and low toxicity and side effects, demonstrates the potential for and offers highly effective treatment. This paper systematically analyzes the mechanism of the PI3K/Akt pathway in UC. It focuses on how TCM metabolites, extracts, and formulas regulate inflammatory responses, oxidative stress, autophagy and apoptosis, intestinal barrier function, and gut microbiota homeostasis by targeting the pathway, which together can achieve the goal of alleviating the symptoms of UC. Our goal is to provide new insights into the prevention and treatment of UC and to contribute to the standardization of TCM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China.
- Department of Gastroenterology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
Zitieren
APA
Niu, S., & Zhang, Y. (2025). Targeting the PI3K/Akt pathway for the treatment of ulcerative colitis: integrative regulatory features of traditional Chinese medicine. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1620138
Vancouver
Niu S, Zhang Y. Targeting the PI3K/Akt pathway for the treatment of ulcerative colitis: integrative regulatory features of traditional Chinese medicine. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1620138
BibTeX
@article{Niu2025,
author = {Niu, Siying and Zhang, Yang},
title = {Targeting the PI3K/Akt pathway for the treatment of ulcerative colitis: integrative regulatory features of traditional Chinese medicine},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1620138}
}
EUVIMED